Special Bulletin
The ºÚÁÏÕýÄÜÁ¿ Association (AHA) sends members Special Bulletins on the latest health care news, legislation, and advocacy opportunities for hospitals and health systems.
The Supreme Court of the United States June 15 ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services (HHS) to significantly cut payments to certain hospitals that participate in the 340B…
We expect that today’s decision will have practical impacts on hospitals and health systems, including on health care provided across state lines, EMTALA obligations, maternal health care, the clinician-patient relationship, medical education and access to care for individuals regardless of…
The Supreme Court of the United States today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug…
While this rule includes no major changes to the structure of the HH PPS, the AHA is very concerned about the unprecedented behavioral offset the agency proposes — 6.9 percentage points — which it states is necessary to achieve budget neutral implementation of the Patient-driven Groupings Model (…
The AHA today released a new video featuring some of the accomplishments and key initiatives the association has undertaken to support members during the first part of this year.
The ºÚÁÏÕýÄÜÁ¿ Association (AHA) today released the Schedule H tax year 2019 benchmark reports.
Leaders from GE Healthcare May 18 joined AHA in a webinar designed to provide members with an update on the contrast dye shortage. During the webinar, GE Healthcare General Manager for Contrast Media in the United States, Greg Eppink, shared that the firm’s production capacity is improving and that…
The AHA Wednesday, May 18 at 3 p.m. ET will host a webinar for AHA members during which GE Healthcare will provide an update on the shortage of its Omnipaque (iohexol) and Visipaque (iodixanol) intravenous contrast media products for computed tomography imaging.
The Centers for Medicare & Medicaid Services (CMS) April 29 finalized its Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Program for Contract Year (CY) 2023.
The AHA commends CMS on the updates to the network adequacy standards, which are critical to ensuring that patients have access to the care they need. We also strongly support CMS’ attention to advancing health equity and look forward to continued partnership on this important work.